Benzodiazepine use

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC N05BA
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_BZD

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 30359 18461 11898
Unadjusted prevalence (%) 11.68 12.56 10.52
Mean age at first event (years) 47.04 46.28 48.22

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.86 [1.62, 2.13] 7.7e-19 3769
15 years 0.01 2.13 [1.90, 2.39] 2.5e-38 2742
5 years 0.00 3.12 [2.80, 3.48] 1.4e-91 990
1 year 0.00 3.27 [2.70, 3.95] 1.1e-34 200

Correlations

Index endpoint: RX_BZD – Benzodiazepine use
GWS hits:

Survival analyses between endpoints

Plot

before Benzodiazepine use
after Benzodiazepine use

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benzodiazepine use